Global ADME DMPK Studies Market Growth (Status and Outlook) 2024-2030

Drug metabolism and pharmacokinetics (DMPK) studies are a type of preclinical study that is used to assess the absorption, distribution, metabolism, and excretion (ADME) of a drug candidate. This information is essential for understanding how a drug will behave in the body and for designing safe and effective clinical trials.

DMPK studies can be performed in vitro or in vivo. In vitro DMPK studies are typically used to screen a large number of compounds for their ADME properties and to identify promising candidates for further development. In vivo DMPK studies are typically performed later in drug development, after a compound has been shown to have promising ADME properties in vitro.

The global ADME DMPK Studies market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “ADME DMPK Studies Industry Forecast” looks at past sales and reviews total world ADME DMPK Studies sales in 2022, providing a comprehensive analysis by region and market sector of projected ADME DMPK Studies sales for 2023 through 2029.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ADME DMPK Studies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

• Segmentation by Type:
• In Vitro
• In Vivo

• Segmentation by Application:
• Pharmaceutical Companies
• Medical Device Companies
• Others

• This report also splits the market by region:
• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia

Europe

• Germany
• France
• UK
• Italy
• Russia

Middle East & Africa

• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Global key ADME DMPK Studies players cover:

• Charles River
• Labcorp
• Eurofins Scientific
• PPD
• Inotiv

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Charles River
• Labcorp
• Eurofins Scientific
• PPD
• Inotiv
• ChemPartner
• Evotec
• Medicilon
• Crown Bioscience
• Jubilant Biosys
• Creative Biolabs
• Allucent
• Sai Life Sciences
• Sygnature Discovery
• Q2 Solutions
• Invitrocue
• Frontage
• BioDuro-Sundia
• Wuxi AppTec
• Pharmaron
• JOINN Laboratories
• Tigermed